These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19995395)

  • 41. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
    Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
    Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia.
    Kneitz C; Goller M; Seggewiss R; Yaman A; Serfling E; Tony HP
    Leuk Res; 2000 Apr; 24(4):331-7. PubMed ID: 10713330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia.
    Goller ME; Kneitz C; Mehringer C; Müller K; Jelley-Gibbs DM; Gosselin EJ; Wilhelm M; Tony HP
    Leuk Res; 2002 Sep; 26(9):795-802. PubMed ID: 12127553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
    Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
    J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
    Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
    Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch2 regulates the development of marginal zone B cells through Fos.
    Iwahashi S; Maekawa Y; Nishida J; Ishifune C; Kitamura A; Arimochi H; Kataoka K; Chiba S; Shimada M; Yasutomo K
    Biochem Biophys Res Commun; 2012 Feb; 418(4):701-7. PubMed ID: 22293205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
    Gu B; Bendall LJ; Wiley JS
    Blood; 1998 Aug; 92(3):946-51. PubMed ID: 9680363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.
    Mangolini M; Götte F; Moore A; Ammon T; Oelsner M; Lutzny-Geier G; Klein-Hitpass L; Williamson JC; Lehner PJ; Dürig J; Möllmann M; Rásó-Barnett L; Hughes K; Santoro A; Méndez-Ferrer S; Oostendorp RAJ; Zimber-Strobl U; Peschel C; Hodson DJ; Schmidt-Supprian M; Ringshausen I
    Nat Commun; 2018 Sep; 9(1):3839. PubMed ID: 30242258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
    Shukla V; Shukla A; Joshi SS; Lu R
    Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
    Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
    Immunol Cell Biol; 2014 Aug; 92(7):591-604. PubMed ID: 24797583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selection of autologous CD4+ T-cells for adoptive T-cell substitution in patients with CD23+ B-cell CLL.
    Dettke M; Berger R; Jurko S; Mitterbauer G; Schwarzmeier JD; Höcker P
    Cytotherapy; 2002; 4(2):119-25. PubMed ID: 12006207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic lymphocytic leukaemia: a review of the immuno-architecture.
    Rosati S; Kluin PM
    Curr Top Microbiol Immunol; 2005; 294():91-107. PubMed ID: 16323429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
    Poe JC; Jia W; Su H; Anand S; Rose JJ; Tata PV; Suthers AN; Jones CD; Kuan PF; Vincent BG; Serody JS; Horwitz ME; Ho VT; Pavletic SZ; Hakim FT; Owzar K; Zhang D; Blazar BR; Siebel CW; Chao NJ; Maillard I; Sarantopoulos S
    Blood; 2017 Nov; 130(19):2131-2145. PubMed ID: 28851699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1.
    Fiorcari S; Maffei R; Atene CG; Mesini N; Maccaferri M; Leonardi G; Martinelli S; Paolini A; Nasillo V; Debbia G; Potenza L; Luppi M; Marasca R
    Front Oncol; 2021; 11():777587. PubMed ID: 35070982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.
    Gassner FJ; Zaborsky N; Catakovic K; Rebhandl S; Huemer M; Egle A; Hartmann TN; Greil R; Geisberger R
    Br J Haematol; 2015 Aug; 170(4):515-22. PubMed ID: 25940792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
    Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
    Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coupling of early response gene expression to distinct regulatory pathways during alpha-interferon and phorbol ester-induced plasmacytoid differentiation of B chronic lymphocytic leukaemia cells.
    Murphy JJ; Norton JD
    FEBS Lett; 1990 Jul; 267(2):242-4. PubMed ID: 2116321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation.
    Fournier S; Rubio M; Delespesse G; Sarfati M
    Blood; 1994 Sep; 84(6):1881-6. PubMed ID: 8080994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of CLL: high CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation.
    Dadmarz R; Cawley JC
    Br J Haematol; 1988 Mar; 68(3):279-82. PubMed ID: 2965599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.